Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice

Glycemic Control and Complications in Type 2 Diabetes Mellitus

(2010) Mark Stolar   AMERICAN JOURNAL OF MEDICINE

Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes

(2010) Wissam H. Faour et al.   CELLULAR SIGNALLING

The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential

(2010) H. Y. Chen et al.   DIABETES

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

(2010) T. Jiang et al.   DIABETES

Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus

(2009) Joan Y. Summy-Long et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Hyperglycemic kidney damage in an animal model of prolonged critical illness

(2009) Ilse Vanhorebeek et al.   KIDNEY INTERNATIONAL

APPLICATION OF AN ADENOVIRAL VECTOR ENCODING SOLUBLE TRANSFORMING GROWTH FACTOR-β TYPE II RECEPTOR TO THE TREATMENT OF DIABETIC NEPHROPATHY IN MICE

(2008) Takehito Kondo et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Attenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment

(2008) Adam Whaley-Connell et al.   HYPERTENSION

A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic Nephropathy

(2008) Y. Huang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

(2007) M. Petersen et al.   KIDNEY INTERNATIONAL